About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Houston | 132 Studies

Clinical Trials SchizophreniaHouston

Schizophrenia Clinical Trials in Houston

Find 132 clinical trials for schizophrenia near Houston, Texas. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 132 trials

CompletedLong-Acting Injectable Risperidone in the Treatment of SchizophreniaIn the proposed study 450 veterans with a primary diagnosis of schizophrenia who had at least one psychiatric hospitalization for schizophrenia in the previous 2 years would be…NCT00132314·Tuscaloosa, Alabama and 18 others CompletedA Study of Strategies to Improve Schizophrenia TreatmentThe goal of this project is to translate research findings about key aspects of antipsychotic treatment into routine care through a multi-component intervention, focusing on…NCT00156637·Fayetteville, Arkansas and 3 others

Schizophrenia Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaThe primary objective of the study is to evaluate the long-term safety and tolerability of TV-46000.NCT03893825·Phoenix, Arizona and 89 others

RecruitingA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)The purpose of this study is to evaluate the safety and efficacy of KarXT in adult participants with mild to severe Alzheimer's Disease (AD) with moderate to severe psychosis…NCT06585787·Chandler, Arizona and 295 others

CompletedTrial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With SchizophreniaThe primary purpose of this study is to evaluate the overall efficacy of aripiprazole intramuscular (IM) depot as acute treatment in subjects with schizophrenia.NCT01663532·Little Rock, Arkansas and 48 others

CompletedEffectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With SchizophreniaThe primary objectives of this study are to evaluate the efficacy and safety of 3 fixed doses of paliperidone palmitate administered i.m. after an initial loading dose of 150 mg…NCT00590577·Anaheim, California and 65 others

TerminatedStudy Evaluating Bifeprunox in Patients With Schizophrenia.An open-label extension study using a variable dose (20 to 30 mg daily) of bifeprunox to evaluate long-term safety.NCT00366327·Little Rock, Arkansas and 81 others

CompletedEffects of Cariprazine on Cardiac Repolarization in Patients With SchizophreniaThis study will evaluate the effects of sequential multiple dose regimens of cariprazine on cardiac repolarization in patients with schizophrenia.NCT01376076·Glendale, California and 3 others

RecruitingAlternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation TreatmentThe purpose of the study is to test the hypothesis that functionally navigated repetitive TMS stimulations to the prefrontal cortex (PFC) modulate aberrant cortical electrical…NCT02916810·Houston, Texas

RecruitingCircuitry-Guided Smoking Cessation in Schizophrenia (UH3)Patients with schizophrenia spectrum disorder (SSD) will be exposed to active repetitive transcranial magnetic stimulation (rTMS) from F8 coil or active rTMS from H coil for…NCT05276050·Houston, Texas

CompletedStudy of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of SchizophreniaThis study evaluates the efficacy of two prescription digital therapeutics (PDT) in addition to standard of care (SOC) therapy for the treatment of experiential negative symptoms…NCT05838625·Chandler, Arizona and 53 others

CompletedProof of Concept Study of Cognitive Improvement in Patients With SchizophreniaThe purpose of this study is to demonstrate that AZD3480 improves cognition in patients with stable schizophrenia who are being treated with an atypical antipsychotic and who are…NCT00528905·Little Rock, Arkansas and 79 others

CompletedA Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaThis is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequate response to their current…NCT05145413·Phoenix, Arizona and 165 others

CompletedA Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With SchizophreniaThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, parallel-group, 6-week trial to evaluate the efficacy, safety, and tolerability of 2 fixed doses of…NCT05227690·Little Rock, Arkansas and 24 others

CompletedSafety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With SchizophreniaThe purpose of this study is to assess the long-term safety, tolerability and efficacy of oral OPC-34712 as monotherapy in adults with schizophrenia.NCT01397786·Birmingham, Alabama and 147 others

CompletedOpen-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With SchizophreniaThe phase 3 Trial 31-12-291 is part of the aripiprazole IM depot clinical development program and has been designed to demonstrate the efficacy and safety of aripiprazole IM depot…NCT01683058·Little Rock, Arkansas and 37 others

TerminatedA Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX StudyThis study is open to adults with schizophrenia who took part in a previous CONNEX study (study 1346-0011, 1346-0012, or 1346-0013).NCT05211947·Anaheim, California and 302 others

CompletedClinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)This study is open to adults with schizophrenia. Schizophrenia can affect the way a person thinks, their memory and their mental functioning.NCT04846868·Garden Grove, California and 115 others

CompletedComparison of Optimal Antipsychotic Treatments for Adults With SchizophreniaThis study will compare the safety and effectiveness of three different antipsychotic medications, as well as the use of other medications to limit treatment side effects, in…NCT00802100·Colton, California and 12 others

RecruitingOcrelizumab for Psychosis by AutoimmunitySome people who have what doctors currently call schizophrenia or bipolar disease may actually have a brain disease caused by auto-antibodies.NCT03971487·Houston, Texas

PreviousPage 5 of 7Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia